Redsense Medical AB (REDS) — Capital Reinvestment Ratio
Latest as of March 2025:
0.14x
Redsense Medical AB (REDS) has a Capital Reinvestment Ratio of 0.14x as of March 2025, meaning it reinvests 0% of its operating cash flow (Skr761.00K) in capital expenditures (Skr105.00K). See Redsense Medical AB (REDS) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.14x
Capex / Operating Cash Flow
Operating Cash Flow
Skr761.00K
SEK
Capital Expenditures
Skr105.00K
SEK
Data as of
Mar 2025
Most recent filing
Redsense Medical AB Capital Reinvestment Ratio (2020–2020)
This chart tracks Redsense Medical AB's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Redsense Medical AB (2020–2020)
Year-by-year Capital Reinvestment Ratio for Redsense Medical AB from 2020 to 2020. For live market cap and broader valuation context, see market value of Redsense Medical AB.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 2.15x | Skr17.23 Million | Skr37.08 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow